Repligen share price today

(RGEN)

Repligen share price is $144.46 & ₹12,275.63 as on 21 Dec 2024, 2.30 'hrs' IST

$144.46

▲

-2.08

(-1.42%)

Market is closed - opens 8 PM, 23 Dec 2024

View live Repligen share price in Dollar and Rupees. Guide to invest in Repligen from India. Also see the sentimental analysis on Indian investors investing in Repligen. Get details on the Indian mutual funds that are investing in Repligen. Get Analyst recommendations and forecasts along with all the Repligen's financials.

Repligen share price movements

Today's Low: $144.26
Today's High: $150.55
$144.46
0.14%
Downside
Day's Volatility :4.17%
Upside
4.04%
52 Weeks Low: $113.50
52 Weeks High: $211.13
$144.46
21.43%
Downside
52 Weeks Volatility :46.24%
Upside
31.58%

Repligen Returns

Period	Repligen Corp	Sector (Health Care)	Index (Russel 2000)
3 Months	2.87%	-11.1%	0.0%
6 Months	16.83%	-6.0%	0.0%
1 Year	-20.94%	2.7%	0.0%
3 Years	-46.43%	0.6%	-19.7%

Repligen Key Statistics

in dollars & INR

Previous Close	$146.54
Open	$145.7
Today's High	$150.545
Today's Low	$144.26
Market Capitalization	$8.2B
Today's Volume	$1.1M
52 Week High	$211.13
52 Week Low	$113.5
Revenue TTM	$639.9M
EBITDA	$100.5M
Earnings Per Share (EPS)	$-0.03
Profit Margin	-0.33%
Quarterly Earnings Growth YOY	-0.83%
Return On Equity TTM	-0.1%

How to invest in Repligen from India?

It is very easy for Indian residents to invest directly in Repligen from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Repligen stock in both Indian Rupees (INR) and US Dollars (USD). Search for Repligen or RGEN on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Repligen or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Repligen shares which would translate to 0.006 fractional shares of Repligen as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India , including recognised companies like Repligen, in just a few clicks!

Returns in Repligen for Indian investors in Rupees

Investment Value

₹1,00,000

Repligen investment value today

Current value as on today

₹1,23,135

Returns

₹23,135

(+23.14%)

Returns from Repligen Stock

₹20,939 (false-20.94%)

Dollar Returns

₹2,196 (+2.2%)

Indian investors sentiment towards Repligen

-71%

Period: Sep 21, 2024 to Dec 20, 2024. Change in 30 Days versus previous period

Search volume for Repligen on INDmoney from India has reduced in the last 30 days as on Dec 21, 2024. -71% less investors are searching Repligen in the last 30 days versus the previous period.

Global Institutional Holdings in Repligen

BlackRock Inc
13.51%
T. Rowe Price Associates, Inc.
11.41%
Vanguard Group Inc
9.00%
State Street Corp
2.90%
Champlain Investment Partners, LLC
2.54%
Sands Capital Management, LLC
2.53%

Analyst Recommendation on Repligen

Buy

78%Buy

21%Hold

0%Sell

Based on 19 Wall street analysts offering stock ratings for Repligen(by analysts ranked 0 to 5 stars)

Based on 19 analyst

Current
1M Ago
3M Ago

Buy

Hold

Sell

Analyst Forecast on Repligen

What analysts predicted

Upside of 32.54%

Current:

$144.46

Target:

$191.46

Insights on Repligen

Price Movement
In the last 7 days, RGEN stock has moved down by -7.6%
Increasing Revenue
Revenue is up for the last 3 quarters, 151.34M → 154.87M (in $), with an average increase of 1.1% per quarter
Decreasing Net Profit
Netprofit is down for the last 2 quarters, 3.32M → -654.0K (in $), with an average decrease of 119.7% per quarter
RGEN vs ISRG (1 yr)
In the last 1 year, Intuitive Surgical, Inc. has given 57.3% return, outperforming this stock by 78.0%
RGEN vs ISRG (3 yr)
In the last 3 years, Intuitive Surgical, Inc. has given 50.7% return, outperforming this stock by 96.7%
Price to Sales
ForRGEN every $1 of sales, investors are willing to pay $12.6, whereas for Intuitive Surgical, Inc., the investors are paying $23.6 for every $1 of sales.

Repligen Financials in INR & Dollars

	FY18	Y/Y Change
Revenue	$194.0M	↑ 37.38%
Net Income	$16.6M	↓ 41.39%
Net Profit Margin	8.56%	↓ 11.51%

	FY19	Y/Y Change
Revenue	$270.2M	↑ 39.28%
Net Income	$21.4M	↑ 28.85%
Net Profit Margin	7.92%	↓ 0.64%

	FY20	Y/Y Change
Revenue	$366.3M	↑ 35.53%
Net Income	$59.9M	↑ 179.88%
Net Profit Margin	16.36%	↑ 8.44%

	FY21	Y/Y Change
Revenue	$670.5M	↑ 83.08%
Net Income	$128.3M	↑ 114.08%
Net Profit Margin	19.13%	↑ 2.77%

	FY22	Y/Y Change
Revenue	$801.5M	↑ 19.54%
Net Income	$186.0M	↑ 44.95%
Net Profit Margin	23.2%	↑ 4.07%

	FY23	Y/Y Change
Revenue	$638.8M	↓ 20.31%
Net Income	$41.6M	↓ 77.64%
Net Profit Margin	6.51%	↓ 16.69%

	Q2 FY23	Q/Q Change
Revenue	$159.2M	↓ 12.86%
Net Income	$20.1M	↓ 30.4%
Net Profit Margin	12.61%	↓ 3.17%

	Q3 FY23	Q/Q Change
Revenue	$141.2M	↓ 11.29%
Net Income	$18.2M	↓ 9.43%
Net Profit Margin	12.87%	↑ 0.26%

	Q4 FY23	Q/Q Change
Revenue	$155.7M	↑ 10.31%
Net Income	$-25.5M	↓ 240.26%
Net Profit Margin	-16.37%	↓ 29.24%

	Q1 FY24	Q/Q Change
Revenue	$151.3M	↓ 2.82%
Net Income	$2.1M	↓ 108.22%
Net Profit Margin	1.38%	↑ 17.75%

	Q2 FY24	Q/Q Change
Revenue	$154.1M	↑ 1.8%
Net Income	$3.3M	↑ 58.6%
Net Profit Margin	2.16%	↑ 0.78%

	Q3 FY24	Q/Q Change
Revenue	$154.9M	↑ 0.52%
Net Income	$-654.0K	↓ 119.69%
Net Profit Margin	-0.42%	↓ 2.58%

	FY18	Y/Y Change
Profit	$108.1M	↑ 45.69%

	FY19	Y/Y Change
Profit	$151.1M	↑ 39.85%

	FY20	Y/Y Change
Profit	$209.6M	↑ 38.69%

	FY21	Y/Y Change
Profit	$391.3M	↑ 86.64%

	FY22	Y/Y Change
Profit	$455.7M	↑ 16.47%

	FY23	Y/Y Change
Profit	$284.2M	↓ 37.62%

	Q2 FY23	Q/Q Change
Profit	$79.9M	↓ 20.78%

	Q3 FY23	Q/Q Change
Profit	$36.6M	↓ 54.22%

	Q4 FY23	Q/Q Change
Profit	$67.6M	↑ 84.93%

	Q1 FY24	Q/Q Change
Profit	$75.0M	↑ 10.87%

	Q2 FY24	Q/Q Change
Profit	$68.8M	↓ 8.25%

	Q3 FY24	Q/Q Change
Profit	$77.5M	↑ 12.67%

	FY18	Y/Y Change
Operating Cash Flow	$32.8M	↑ 87.78%
Investing Cash Flow	$-14.0M	↓ 85.71%
Financing Cash Flow	$3.4M	↓ 97.38%

	FY19	Y/Y Change
Operating Cash Flow	$67.2M	↑ 105.11%
Investing Cash Flow	$-205.3M	↑ 1362.62%
Financing Cash Flow	$484.9M	↑ 14131.49%

	FY20	Y/Y Change
Operating Cash Flow	$62.6M	↓ 6.83%
Investing Cash Flow	$-201.4M	↓ 1.91%
Financing Cash Flow	$305.9M	↓ 36.91%

	FY21	Y/Y Change
Operating Cash Flow	$119.0M	↑ 90.05%
Investing Cash Flow	$-221.2M	↑ 9.82%
Financing Cash Flow	$961.0K	↓ 99.69%

	FY22	Y/Y Change
Operating Cash Flow	$172.1M	↑ 44.59%
Investing Cash Flow	$-233.2M	↑ 5.46%
Financing Cash Flow	$-13.3M	↓ 1487.83%

	Q2 FY23	Q/Q Change
Operating Cash Flow	$34.5M	↑ 209.02%
Investing Cash Flow	$64.8M	↓ 787.3%
Financing Cash Flow	$-8.8M	↓ 7.72%

Repligen Technicals Summary

Sell

Neutral

Buy

Repligen is currently in a neutral trading position according to technical analysis indicators.

Repligen Vs Peers

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Repligen Corp	1.9%	16.83%	-20.94%	-46.43%	55.8%
Intuitive Surgical, Inc.	-4.76%	22.23%	55.96%	44.79%	163.35%
Resmed Inc.	-2.6%	30.23%	38.43%	-9.34%	52.4%
Becton, Dickinson And Company	0.99%	-3.49%	-6.3%	-8.13%	-16.75%
West Pharmaceutical Services Inc	3.28%	0.12%	-6.63%	-26.94%	119.17%
Alcon Ag	-0.95%	-5.74%	9.86%	-1.7%	48.16%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Repligen Corp	492.86	NA	2.59	1.54	0.0	0.0	NA	35.53
Intuitive Surgical, Inc.	84.09	84.09	3.89	6.85	0.16	0.08	NA	43.75
Resmed Inc.	30.67	30.67	1.75	7.71	0.24	0.13	0.01	35.39
Becton, Dickinson And Company	38.13	38.13	1.02	13.11	0.06	0.03	0.02	89.47
West Pharmaceutical Services Inc	48.52	48.52	6.07	6.66	0.18	0.1	0.0	37.96
Alcon Ag	35.97	35.97	3.05	3.03	0.06	0.03	0.0	43.25

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Repligen Corp	Buy	$8.2B	55.8%	492.86	-0.33%
Intuitive Surgical, Inc.	Buy	$186.6B	163.35%	84.09	28.51%
Resmed Inc.	Buy	$34.0B	52.4%	30.67	23.15%
Becton, Dickinson And Company	Buy	$64.7B	-16.75%	38.13	7.13%
West Pharmaceutical Services Inc	Buy	$23.7B	119.17%	48.52	17.37%
Alcon Ag	Buy	$41.6B	48.16%	35.97	11.89%

About Repligen

repligen corporation is a life sciences company focused on the development, production and commercialization of products used in the process of manufacturing biological drugs. our bioprocessing products are sold to major life sciences and biopharmaceutical companies worldwide. we are a leading manufacturer of protein a, a critical reagent used to manufacture monoclonal antibody-based therapeutics. we also supply several growth factor products used to increase cell culture productivity in biomanufacturing. in the burgeoning area of disposable biomanufacturing technologies, we have developed and market a series of opus™ (open platform user specified) single-use chromatography columns used in the biologics purification process. repligen’s corporate headquarters are located in waltham, ma, usa; we have an additional manufacturing facility in lund, sweden.

Organization	Repligen
Employees	1783
CEO	Mr. Anthony J. Hunt
Industry	Health Technology

Management People of Repligen

Name	Title
Mr. Anthony J. Hunt	Executive Chair
Mr. Olivier Loeillot	President, CEO & Director
Mr. Jason K. Garland	CFO & Chief Compliance Officer
Mr. James R. Bylund	Chief Operating Officer
Mr. Ralf Kuriyel	Senior Vice President of Research & Development
Mr. Keith Lee Robinson	Chief Information Officer
Ms. Sondra S. Newman	Global Head of Investor Relations
Ms. Kimberly A. Cornwell	Global Head of Legal
Mr. Neil Whitfield	VP & Global Head of Sales
Ms. Teresa Ferragamo	Senior Director of Marketing

Important FAQs about investing in Repligen from India :

What is Repligen share price today?

Repligen share price today stands at $144.46, Open: $145.70 ; Previous Close: $146.54 ; High: $150.55 ; Low: $144.26 ; 52 Week High: $211.13 ; 52 Week Low: $113.50. The stock opens at $145.70, after a previous close of $146.54. The stock reached a daily high of $150.55 and a low of $144.26, with a 52-week high of $211.13 and a 52-week low of $113.50.

Can Indians buy Repligen shares?

Yes, Indians can invest in the Repligen (RGEN) from India.

With INDmoney, you can buy Repligen at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy Repligen at zero transaction cost.

How can I buy Repligen shares from India?

It is very easy to buy Repligen from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Repligen be purchased?

Yes, you can buy fractional shares of Repligen with INDmoney app.

What are the documents required to start investing in Repligen stocks?

To start investing in Repligen, You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.